Investing In PDS Biotechnology Corporation (NASDAQ: PDSB) Does Not Require High Risk Tolerance
During the last session, PDS Biotechnology Corporation (NASDAQ:PDSB)’s traded shares were 0.55 million, with the beta value of the company hitting 1.85. At the end